Dermabrasion of large congenital melanocytic naevi in neonates

Area of Science:

• Dermatology
• Pediatric Surgery

Background:

• Large congenital melanocytic nevi (LCMN) present significant cosmetic and potential health concerns.
• Early intervention is crucial for managing congenital skin conditions in newborns.

Purpose of the Study:

• To evaluate the efficacy and long-term outcomes of early-life dermabrasion for treating large congenital melanocytic nevi.
• To assess the safety and cosmetic results of dermabrasion in infants.

Main Methods:

• A retrospective review of 12 infants with LCMN treated with dermabrasion within the first 14 weeks of life.
• Postoperative follow-up ranged from 1 to 16 years, including assessment of hyperpigmentation reduction and aesthetic outcomes.
• Surgical reconstruction with grafts and flaps was performed in select cases to enhance cosmetic results.

Main Results:

• Dermabrasion achieved significant and stable reduction in hyperpigmentation in 10 out of 12 patients.
• Aesthetic improvement was noted, with reconstructive surgery further enhancing results in six patients.
• One patient developed a minimal deviation melanoma in the treated area seven years post-dermabrasion, with an otherwise uneventful clinical course.

Conclusions:

• Early dermabrasion is a viable treatment option for reducing hyperpigmentation associated with large congenital melanocytic nevi in infants.
• The procedure offers potentially lasting cosmetic benefits, although careful monitoring for rare complications like melanoma is warranted.
• Combined surgical reconstruction can further optimize aesthetic outcomes for treated congenital melanocytic nevi.